Use of human specimens in research: The evolving United States regulatory, policy, and scientific landscape

Diagnostic Histopathology

Volumn 19, Issue 9, 2013, Pages 322-330

  Bledsoe, Marianna J ^a   Grizzle, William E ^b  

^a Silver Spring ^*  (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Biorepositories; Ethical issues; Human specimen research; Human subjects protection regulations; Personalized medicine; Research policy

Indexed keywords

BIOETHICS; CLINICAL DATA REPOSITORY; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH INSURANCE; HUMAN; LEGAL ASPECT; MEDICAL RESEARCH; NATIONAL HEALTH ORGANIZATION; POLICY; PRIVACY; REVIEW; SCIENCE; SOCIAL SECURITY; TISSUE SECTION; UNITED STATES; WELFARE;

EID: 84884168400     PISSN: 17562317     EISSN: 18767621     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2013.06.015     Document Type: Review

References (69)

1. Seok J., Warren H.S., Cuenca A.G., et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013, 110:3507-3512. Inflammation and Host Response to Injury, Large Scale Collaborative Research Program.
2. Grizzle W.E., Moore H.M. Mice model findings and the future of human tissue in disease research. Biopreserv Biobank 2013, 111-112. 10.1089/bio.2013.1132.
3. Korn D. Contribution of the human tissue archive to the advancement of medical knowledge and the public health. Research involving human biological materials: ethical issues and policy guidance 2000, vol. 2:E1-E30. National Bioethics Advisory Commission, Available for download at:, (accessed 25 May 2013). http://bioethics.georgetown.edu/nbac/pubs.html.
4. Grizzle W.E., Srivastava S., Manne U. Translational pathology of neoplasia. Translational pathology of early cancer 2012, 7-20. IOS Press BV, Amsterdam, The Netherlands. S. Srivastava, W.E. Grizzle (Eds.).
5. Grizzle W.E., Srivastava S., Manne U. The biology of incipient, pre-invasive or intraepithelial neoplasia. Translational pathology of early cancer 2012, 21-39. IOS Press BV, Amsterdam, The Netherlands. S. Srivastava, W.E. Grizzle (Eds.).
6. Grizzle W.E., Bell W.C., Sexton K.C. Issues in collecting, processing and storing human tissues and associated information to support biomedical research. Translational pathology of early cancer 2012, 531-549. IOS Press BV, Amsterdam, The Netherlands. S. Srivastava, W.E. Grizzle (Eds.).
7. Srivastava S., Grizzle W.E. Biomarkers and the genetics of early neoplastic lesions. Translational pathology of early cancer 2012, 41-64. IOS Press BV, Amsterdam, The Netherlands. S. Srivastava, W.E. Grizzle (Eds.).
8. Slamon D.J., Leyland-Jones B., Shak S., et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. NEngl J Med 2001, 344:783-792.
9. Jackish C. HER-2-positive metastatic breast cancer: optimizing trastuzumab-based therapy. Oncologist 2006, 11(suppl 1):34-41.
10. Nahta R., Esteva F.J. Trastuzumab: triumphs and tribulations. Oncogene 2007, 26:3637-3643.
11. Von Minckwitz G., Schwedler K., Schmidt M., et al. Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phaseIII study in HER2-positive breast cancer. Eur J Cancer 2011, 4:2273-2281.
12. Ruschoff J., Dietel M., Baretton G., et al. HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing. Virchows Arch 2010, 457:299-307.
13. McNally L.R., Manne U., Grizzle W.E. Post-transcriptional processing of genetic information and its relation to cancer. Biotech Histochem 2013, published on-line January 4, 2013. http://dx.doi.org/10.3109/10520295.2012.730152.
14. Volinia S., Calin G.A., Chang-Gong L., et al. AmicroRNA expression signature of human solid tumors defines cancer gene targets. PNAS 2006, 103:2257-2261.
15. Krützfeldt J., Rajewsky N., Braich R., et al. Silencing of microRNAs invivo with 'antagomirs'. Nature 2005, 438. 10.1038/nature04303.
16. Wu Y., Crawford M., Mao Y., et al. Therapeutic delivery of MicroRNA-29b by cationic lipoplexes for lung cancer. Mol Ther Nucleic Acids 2013, 2:e84. PMID: 23591808. PMCID: PMC3650246.
17. Grizzle W.E., Sexton K.C., Bell W.C. Human tissue biorepository. Molecular genetic pathology 2013, vol. 1:483-497. Springer Science+Business Media. 2nd edn.
18. Hughes S.E., Barnes R.O., Watson P.H. Biospecimen use in cancer research over two decades. Biopreserv Biobank 2010, 8:89-97.
19. Gaston S.M., Soares M.A., Siddiqui M.M., et al. Tissue-print and print-phoresis as platform technologies for the molecular analysis of human surgical specimens: mapping tumor invasion of the prostate capsule. Nat Med 2005, 11:95-101.
20. National Cancer Institute CHTN Cooperative Human Tissue Network (accessed 25 May 2013). http://www.chtn.nci.nih.gov.
21. National Cancer Institute Translational Research Program. (accessed 25 May 2013). http://trp.cancer.gov.
22. National Cancer Institute (NCI) Cooperative Group Banks: Biorepositories for NCI-sponsored Clinical Trials. (accessed 25 May 2013). http://cgb.cancer.gov.
23. Cadigan R.J., Dragana L., Haldeman K., Conlon I., Reavely E., Henderson G.E. Neglected ethical issues in biobank management: results from a U.S. study. Life Sci Soc Pol 2013, 9:1. Published on-line March 2013.
24. Code of Federal Regulations. Title 45. Public Welfare. Department of Health and Human Services. Part 45. Protection of Human Subjects. (accessed 25 May 2013). http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.html.
25. Code of Federal Regulations. Title 21. Food and Drugs. Chapter I - Food and Drug Administration. Department of Health and Human Services. Subchapter A. General Part 50. Protection of Human Subjects. (accessed 25 May 2013). http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?CFRPart=50%26showFR=1.
26. Code of Federal Regulations. Title 21. Food and Drugs. Chapter I - Food and Drug Administration. Department of Health and Human Services. Subchapter A. General. Part 56. Institutional Review Boards. (accessed 25 May 2013). http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?cfrpart=56.
27. Code of Federal Regulations. Title 21. Food and Drugs. Chapter I - Food and Drug Administration. Department of Health and Human Services. Subchapter H. Medical Devices. Part 812. Investigational Device Exemptions. (accessed 25 May 2013). http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?cfrpart=812.
28. U.S. Department of Health and Human Services. Combined Text of All Rules [45 CFR Parts 160, 162, and 164]. Available for download at: (accessed 17 June 2013). http://www.hhs.gov/ocr/privacy/hipaa/administrative/combined/index.html.
29. Bell W.C., Sexton K.C., Grizzle W.E. How to efficiently obtain human tissues to support specific biomedical research projects. Cancer Epidemiol Biomark Prev 2009, 18:1676-1679.
30. "OHRP Guidance on Research Involving Coded Private Information or Biological Specimens" (accessed 25 May 2013). http://www.hhs.gov/ohrp/humansubjects/guidance/cdebiol.pdf.
31. Human subjects research protections: enhancing protections for research subjects and reducing burden, delay, and ambiguity for investigators. Federal Register. July 26, 2011. 76 CFR 44512. HHS-OPHS-2011-005.
32. FDA. "Guidance on informed Consent for InVitro Diagnostic Device Studies Using Leftover Human Specimens that are Not Individually Identifiable" (accessed 25 May 2013). 34. http://www.fda.gov/cdrh/oivd/guidance/1588.html.
33. U.S. Department of Health and Human Services, Protecting Personal Health Information in Research: Understanding the HIPAA Privacy Rule. Available for download at: (accessed 25 May 2013). http://privacyruleandresearch.nih.gov/pr_02.asp.
34. U.S. Department of Health and Human Services, Guidance Regarding Methods for De-identification of Protected Health Information in Accordance with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule. (accessed 25 May 2013). http://www.hhs.gov/ocr/privacy/hipaa/understanding/coveredentities/De-identification/guidance.html.
35. Hakimian R., Taube S., Bledsoe M., Aamodt R. National Cancer Institute Cancer Diagnosis Program: 50-State survey of laws regarding the collection, Storage, and use of human tissue specimens and associated data for research 2004, National Institutes of Health, Bethesda, MD, NIH publication 05-5628, (accessed 25 May 2013). http://cdp.cancer.gov/humanSpecimens/survey/index.htm.
36. U.S. Department of Health and Human Services, National Institutes of Health. Genome-Wide Association Studies (GWAS). (accessed 25 May 2013). http://gwas.nih.gov/.
37. U.S. Department of Health and Human Services, Office for Human Research Protections. International Compilation of Human Research Standards. (accessed 25 May 2013). http://www.hhs.gov/ohrp/international/intlcompilation/intlcompilation.html.
38. The Royal Liverpool Children's Inquiry: Summary and Recommendations. The House of Commons, January 30, 2001. (accessed 25 May 2013). http://www.official-documents.gov.uk/document/hc0001/hc00/0012/0012_i.pdf.
39. The National Archives. Legislation.gov.uk. Human Tissue Act 2004. (accessed 25 May 2013). http://www.legislation.gov.uk/ukpga/2004/30/contents.
40. Skloot R. The Immortal Life of Henrietta Lacks 2010, Crown Publishing, Random House, Inc, New York.
41. Skloot R. The Immortal Life of Henrietta Lacks, the Sequel March 23 2013, New York Times.
42. Travis J. Privacy Flap Forces Withdrawal of DNA Data on Cancer Cell Line 2013, Science Insider. March 26, 2013.
43. Grody W.W., Howell R.R. The fate of newborn screening blood spots. Pediatr Res 2010, 67:237.
44. Fikac P. State to destroy newborns' blood samples December 22, 2009, The Houston Chronicle, (accessed 25 May 2013). http://www.chron.com/news/houston-texas/article/State-to-destroy-newborns-blood-samples-1599212.php.
45. Moore v Regents of the University of California, 793 P 2d 479 (Cal Rptr 146 1990).
46. Greenberg v Miami Children's Hospital Research Institute, 264 F Supp 2d 1064 (SD Fla 2003).
47. Washington University v Catalona, 437 F Supp 2d 985 (ED Mo 2006).
48. Washington University v Catalona, 400 F 3d 667(8th Cir 2007).
49. Kaiser J. Court decides tissue samples belong to university, not patients. Science 2006, 312:346.
50. Hakimian R., Korn D. Ownership and use of tissue specimens for research. JAMA 2004, 292:2500-2505.
51. Kiefer M. Havasupai Tribe ends regents lawsuit with burial April 22, 2010, The Arizona Republic, Available for download at:, (accessed 25 May 2013). http://www.azcentral.com/arizonarepublic/local/articles/2010/04/22/20100422arizona-havasupai-tribe-regents-lawsuit.html.
52. Mello M.M., Wolf L.E. The Havasupai Indian tribe case: lessons for research involving stored biologic samples. NEngl J Med 2010, 363:204-207.
53. Campbell L., Betsou F., Garcia D.L., et al. ISBER. 2012 Best Practices for Repositories: Collection, storage, retrieval and distribution of biological materials for research, 3rd edn. Biopreserv Biobank 2012, 10:79-161. Available for download at: https://isber.site-ym.com/?page=BPR.
54. Best Practices for Biospecimen Resources 2011, National Cancer Institute, Available for download at:, (accessed on 25 May 2013). http://biospecimens.cancer.gov/practices/.
55. Guidelines for Human Biobanks and Genetic Research Databases 2009, Organisation for Economic Cooperation and Development (OECD), Available for download at: http://www.oecd.org/sti/biotech/guidelinesforhumanbiobanksandgeneticresearchdatabaseshbgrds.htm. (accessed 25 May 2013).
56. Emanuel E.J., Menikoff J. Reforming the regulations governing research with human subjects. NEJM 2011, 365:1145-1150.
57. Homer N., Szelinger S., Redman M., et al. Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP Genotyping Microarrays. PLOS Genet August 29 2008.
58. NCBI Database of Genotypes and Phenotypes. (accessed 25 May 2013). http://www.ncbi.nlm.nih.gov/gap.
59. Zerhouni E.A., Nabel E.G. Protecting aggregate genomic data. Science 2008 Oct 3, 322:44.
60. Gymrek M., McGuire A.L., Golan D., Halperin E., Erlich Y. Identifying personal genomes by surname inference. Science 2013, 339:321-324.
61. Wolf S.M., Lawrenz F.P., Nelson C.A., et al. Managing incidental findings in human subjects research: analysis and recommendations. JLaw Med Ethics 2008, 36:219-248.
62. Fabsitz R.R., McGuire A., Sharp R.R., et al. National Heart, Lung and Blood Institute working group: ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung and Blood Institute working group. Cir Cardiovasc Genet 2010, 3:574-580.
63. Wolf S.M., Crock B.N., Van Ness B., et al. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med 2012, 14:361-384.
64. Bledsoe M.J., Grizzle W.E., Clark B.J., Zeps N. Practical implementation issues and challenges for biobanks in the return of individual research results. Genet Med 2012, 14:478-483.
65. Bledsoe M.J., Clayton E.W., McGuire A.L., Grizzle W.E., O'Rourke P.P., Zeps N. Return of research results from genomic biobanks: cost matters. Genet Med 2013, 15:103-105.
66. Privacy and Progress in Whole Genome Sequencing October 2012, The Presidential Commission for the Study of Bioethical Issues, Available for download at: http://bioethics.gov/node/764. (accessed 25 May 2013).
67. National Archives and Records Administration. The Federal Register. (accessed 27 May 2013). https://www.federalregister.gov/.
68. Regulations.gov. (accessed 27 May 2013). http://www.regulations.gov/#!home.
69. The International Society for Biological and Environmental Repositories. (accessed 17 June 2013). http://www.isber.org/.